Covered recipient · General Payments record
JOACHIM WERNICKE
General Payments · PY2018–2020
$355,807.51
- Reported across 102 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2020 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $154,125.00 | 40 |
By paying entity
PY2020 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $154,125.00 | 40 |
By program year
All program years on this page · sorted by year
Payment records · PY2020 (40)
Sorted by paying entity, then date · as published by CMS
Program year 2020 20182019
Record-level detail is published for PY2020; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $10,750.00 | 01/01/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179683 | CMS |
| AbbVie Inc. | $7,250.00 | 01/14/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179685 | CMS |
| AbbVie Inc. | $6,000.00 | 01/14/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179687 | CMS |
| AbbVie Inc. | $2,500.00 | 01/14/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179689 | CMS |
| AbbVie Inc. | $3,250.00 | 01/20/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179691 | CMS |
| AbbVie Inc. | $1,750.00 | 01/24/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179693 | CMS |
| AbbVie Inc. | $7,500.00 | 02/20/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179695 | CMS |
| AbbVie Inc. | $3,125.00 | 02/24/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179697 | CMS |
| AbbVie Inc. | $2,625.00 | 03/08/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179699 | CMS |
| AbbVie Inc. | $1,500.00 | 03/15/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179701 | CMS |
| AbbVie Inc. | $2,000.00 | 03/22/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179703 | CMS |
| AbbVie Inc. | $5,000.00 | 03/29/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179705 | CMS |
| AbbVie Inc. | $2,250.00 | 04/05/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179707 | CMS |
| AbbVie Inc. | $2,250.00 | 04/12/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179709 | CMS |
| AbbVie Inc. | $1,125.00 | 04/19/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179711 | CMS |
| AbbVie Inc. | $2,250.00 | 04/26/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179713 | CMS |
| AbbVie Inc. | $1,750.00 | 05/03/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179715 | CMS |
| AbbVie Inc. | $2,250.00 | 05/10/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179717 | CMS |
| AbbVie Inc. | $1,500.00 | 05/17/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179719 | CMS |
| AbbVie Inc. | $1,250.00 | 05/24/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179721 | CMS |
| AbbVie Inc. | $1,750.00 | 05/31/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179723 | CMS |
| AbbVie Inc. | $2,750.00 | 06/07/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179725 | CMS |
| AbbVie Inc. | $2,000.00 | 06/14/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179727 | CMS |
| AbbVie Inc. | $750.00 | 06/21/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179729 | CMS |
| AbbVie Inc. | $2,000.00 | 06/28/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179731 | CMS |
| AbbVie Inc. | $4,125.00 | 07/15/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179733 | CMS |
| AbbVie Inc. | $2,875.00 | 07/17/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179735 | CMS |
| AbbVie Inc. | $1,875.00 | 07/17/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179737 | CMS |
| AbbVie Inc. | $3,000.00 | 08/10/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179739 | CMS |
| AbbVie Inc. | $1,750.00 | 08/17/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179741 | CMS |
| AbbVie Inc. | $10,250.00 | 08/25/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179743 | CMS |
| AbbVie Inc. | $9,500.00 | 08/31/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179745 | CMS |
| AbbVie Inc. | $6,500.00 | 09/04/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179747 | CMS |
| AbbVie Inc. | $6,875.00 | 09/14/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179749 | CMS |
| AbbVie Inc. | $1,500.00 | 09/21/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179751 | CMS |
| AbbVie Inc. | $10,125.00 | 09/21/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179753 | CMS |
| AbbVie Inc. | $11,250.00 | 09/28/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179755 | CMS |
| AbbVie Inc. | $1,750.00 | 10/19/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179757 | CMS |
| AbbVie Inc. | $1,625.00 | 10/29/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179759 | CMS |
| AbbVie Inc. | $4,000.00 | 10/29/2020 | Consulting Fee | Undisputed | 01/23/2026 | 722179761 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020
- Generated from
- OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.